Updates on Emerging Oral Therapies for IBD

Learn about late-phase trial results for emerging oral IBD therapies

Share

Program Content

Activities

  • Clinical Trials
    Advantages of and Barriers to Patient Participation in IBD Clinical Trials
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 17, 2021

    Expires: August 16, 2022

  • Slides: Emerging Oral Tx
    MedicalMinute: Updates on Emerging Oral Therapies for IBD
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 24, 2021

    Expires: August 23, 2022

Faculty

cover img faculity

Millie D. Long, MD, MPH, FACG, AGAF

Professor of Medicine
Director,
Gastroenterology and Hepatology Fellowship Program
Vice-Chief for Education
Division of Gastroenterology and Hepatology
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

ProCE Banner

Supporters

AbbVie

Bristol Myers Squibb